BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2023 Earnings Call Transcript November 2, 2023
BioCryst Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.25.
Operator: Good morning and welcome to the BioCryst Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference to Mr. John Bluth at BioCryst. Please go ahead.
John Bluth: Thank you, Maria. Good...
